TREM2 as an evolving therapeutic target in Alzheimer's disease
Neural Regen Res
.
2023 Dec;18(12):2680-2681.
doi: 10.4103/1673-5374.371360.
Author
Jacob George
1
Affiliation
1
Cognyxx Pharmaceuticals, Tel Aviv Israel and Kaplan Heart Center, Rehovot, Israel.
PMID:
37449620
PMCID:
PMC10358665
DOI:
10.4103/1673-5374.371360
No abstract available